MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
JYNT stock logo

JYNT

The Joint Corp.

$8.6
0.02
 (0.23%)
[ms_data_label text=’Delayed data’]
Exchange:  NASDAQ
Market Cap:  127.849M
Shares Outstanding:  14.004M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Care Facilities
   
CEO:  Sanjiv Razdan
Full Time Employees:  443
Address: 
16767 North Perimeter Drive
Scottsdale
AZ
85260
US
Website:  https://www.thejoint.com
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue46,977.47752,163.43054,895.592
Gross Profit36,496.83240,646.58242,025.957
EBITDA8,879.6082,899.1311,900.919
Operating Income318.299-1,889.025-905.478
Net Income-9,752.197-5,796.8932,907.265

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets87,208.01283,154.40860,966.527
Total Liabilities62,436.13062,476.28945,886.935
Total Stockholders Equity24,746.88220,653.11915,054.592
Total Debt2,860.909795.0262,009.706
Cash and Cash Equivalents18,153.60925,051.35523,601.810

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow14,677.5899,415.0501,838.509
Capital Expenditure-4,999.070-1,185.647-1,503.785
Free Cash Flow9,678.5198,229.403334.724
Net Income-9,752.197-8,529.8432,907.265
Net Change in Cash8,663.8756,782.144-1,694.568

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2027Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)55,203.835Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)60,098.866Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)57,351Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)5,332.861Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)5,805.736Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)5,540.284Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)3,239.478Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)3,617.228Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)3,428.353Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)43,069.386Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)46,888.432Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)44,744.579Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.230Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.240Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.210Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
51.897M  ?P/S
 (TTM)
: 
2.41
?Net Income
 (TTM)
: 
-8529843  ?P/E
 (TTM)
: 
46.19
?Enterprise Value
 (TTM)
: 
110.464M  ?EV/FCF
 (TTM)
: 
330.02
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.14  ?ROIC
 (TTM)
: 
-0.03
?Net Debt
 (TTM)
: 
-25548151  ?Debt/Equity
 (TTM)
: 
0.13
?P/B
 (TTM)
: 
8.92  ?Current Ratio
 (TTM)
: 
1.59

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
45.26Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate JYNT Intrinsic Value

Common questions about JYNT valuation

Is The Joint Corp. (JYNT) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for The Joint Corp. (JYNT) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is JYNT a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether JYNT trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is JYNT’s P/E ratio?

You can see JYNT’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for JYNT?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is JYNT a good long-term investment?

Whether JYNT fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

JYNT

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

0.23
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 7.5   Year High: 13.47
Price Avg 50: 8.97   Price Avg 200: 9.56
Volume: 31486   Average Volume: 61274

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for JYNT

Relevant news

Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
28-04-2026 17:38
Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California
27-04-2026 16:05
The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California
Porsche to Sell Its Stakes in Bugatti Joint Venture and Rimac
24-04-2026 05:04
Porsche to Sell Its Stakes in Bugatti Joint Venture and Rimac
FireFox Gold Provides Update on Kolho Joint Venture Lapland, Finland
23-04-2026 05:30
FireFox Gold Provides Update on Kolho Joint Venture Lapland, Finland
NU E Power Corp. Enters Joint Development Agreement for Darkhan Energy Park and Commences Feasibility Studies
15-04-2026 17:01
NU E Power Corp. Enters Joint Development Agreement for Darkhan Energy Park and Commences Feasibility Studies
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
15-04-2026 09:05
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read